Literature DB >> 33919446

Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.

Michal Kowara1, Agnieszka Cudnoch-Jedrzejewska1.   

Abstract

Atherosclerotic plaque vulnerability is a vital clinical problem as vulnerable plaques tend to rupture, which results in atherosclerosis complications-myocardial infarctions and subsequent cardiovascular deaths. Therefore, methods aiming to stabilize such plaques are in great demand. In this brief review, the idea of atherosclerotic plaque stabilization and five main approaches-towards the regulation of metabolism, macrophages and cellular death, inflammation, reactive oxygen species, and extracellular matrix remodeling have been presented. Moreover, apart from classical approaches (targeted at the general mechanisms of plaque destabilization), there are also alternative approaches targeted either at certain plaques which have just become vulnerable or targeted at the minimization of the consequences of atherosclerotic plaque erosion or rupture. These alternative approaches have also been briefly mentioned in this review.

Entities:  

Keywords:  atherosclerotic plaque; cell death; inflammation; intravascular ultrasound; macrophage; myocardial infarction; necrotic cores; stabilization; vulnerable plaque

Year:  2021        PMID: 33919446     DOI: 10.3390/ijms22094354

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  135 in total

1.  MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.

Authors:  Wei'jia Chen; Fangpu Yu; Mingxue Di; Mengmeng Li; Yifei Chen; Yu Zhang; Xiaolin Liu; Xiaozhen Huang; Mei Zhang
Journal:  Atherosclerosis       Date:  2018-08-26       Impact factor: 5.162

Review 2.  Stabilization of atherosclerotic plaque during lipid lowering.

Authors:  D Müller-Wieland; J Kotzka; W Krone
Journal:  Curr Opin Lipidol       Date:  1997-12       Impact factor: 4.776

3.  Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.

Authors:  Courtney P Judkins; Henry Diep; Brad R S Broughton; Anja E Mast; Elizabeth U Hooker; Alyson A Miller; Stavros Selemidis; Gregory J Dusting; Christopher G Sobey; Grant R Drummond
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-16       Impact factor: 4.733

4.  Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.

Authors:  Zhouqing Huang; Liansheng Wang; Shu Meng; Yue Wang; Ting Chen; Changqian Wang
Journal:  Int J Cardiol       Date:  2009-07-03       Impact factor: 4.164

5.  Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect.

Authors:  D Gómez-Garre; P Muñoz-Pacheco; M L González-Rubio; P Aragoncillo; R Granados; A Fernández-Cruz
Journal:  Br J Pharmacol       Date:  2009-02-16       Impact factor: 8.739

6.  Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.

Authors:  Eline Van Craeyveld; Stephanie C Gordts; Elena Nefyodova; Frank Jacobs; Bart De Geest
Journal:  J Mol Med (Berl)       Date:  2011-01-21       Impact factor: 4.599

Review 7.  Recent insights into the cellular biology of atherosclerosis.

Authors:  Ira Tabas; Guillermo García-Cardeña; Gary K Owens
Journal:  J Cell Biol       Date:  2015-04-13       Impact factor: 10.539

Review 8.  Plaque Calcification During Atherosclerosis Progression and Regression.

Authors:  Atsushi Shioi; Yuji Ikari
Journal:  J Atheroscler Thromb       Date:  2017-12-12       Impact factor: 4.928

9.  Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms.

Authors:  Yuling Tian; Tao Chen; Yan Wu; Lin Yang; Lijun Wang; Xiaojuan Fan; Wei Zhang; Jiahao Feng; Hang Yu; Yanjie Yang; Juan Zhou; Zuyi Yuan; Yue Wu
Journal:  Cardiovasc Diabetol       Date:  2017-10-30       Impact factor: 9.951

10.  Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.

Authors:  Madhusudhan Budatha; Jiasheng Zhang; Zhen W Zhuang; Sanguk Yun; James E Dahlman; Daniel G Anderson; Martin A Schwartz
Journal:  J Am Heart Assoc       Date:  2018-01-30       Impact factor: 5.501

View more
  4 in total

1.  Circulating Exosomal circRNAs Contribute to Potential Diagnostic Value of Large Artery Atherosclerotic Stroke.

Authors:  Qi Xiao; Rongyao Hou; Hong Li; Shuai Zhang; Fuzhi Zhang; Xiaoyan Zhu; Xudong Pan
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

Review 2.  More than Just a Monolayer: the Multifaceted Role of Endothelial Cells in the Pathophysiology of Atherosclerosis.

Authors:  Marion Mussbacher; Klaudia Schossleitner; Julia B Kral-Pointner; Manuel Salzmann; Astrid Schrammel; Johannes A Schmid
Journal:  Curr Atheroscler Rep       Date:  2022-04-11       Impact factor: 5.967

3.  Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology.

Authors:  Tianyue Wang; Yaqiong Zhou; Kaina Wang; Xinyu Jiang; Jingbo Wang; Jing Chen
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 4.  Sphingolipid metabolism and signaling in cardiovascular diseases.

Authors:  Sonia Borodzicz-Jażdżyk; Piotr Jażdżyk; Wojciech Łysik; Agnieszka Cudnoch-Jȩdrzejewska; Katarzyna Czarzasta
Journal:  Front Cardiovasc Med       Date:  2022-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.